2013 APhA In Recognition of Excellence Awards Booklet - American ...

Susan C. Winckler, BSPharm,
JD,
is the President and Chief Executive Officer
of the Food and Drug Law Institute, a nonprofit
501(c)(3) organization committed
to providing a marketplace for discussing
global food and drug law issues. In addition,
Winckler is a Senior Advisor with Leavitt Partners, a health
care intelligence firm founded and led by former Secretary
of Health and Human Services (HHS) Michael O. Leavitt.
From January 2007 to June 2009, she served as the Chief of
the Staff for the Food and Drug Administration within HHS.
In that capacity, she provided integrated policy analysis and
strategic consultation on significant agency issues and programs
to the FDA Commissioner and senior officials. Prior to
joining FDA, Winckler was the Vice President for Policy and
Communications and Staff Counsel for APhA. Prior to joining
APhA, Winckler directed the implementation of the Iowa
Medicaid Drug Prior Authorization Program and worked
for the Iowa Pharmacists Association (now Iowa Pharmacy
Association) and a community pharmacy in the state.
Winckler is a graduate of the University of Iowa College
of Pharmacy and the Georgetown University Law Center,
magna cum laude.
Sharon Lynn Youmans, PharmD,
MPH, BCPS,
is an Associate Professor of Clinical
Pharmacy, Associate Dean for Diversity,
and Vice Chair for Educational Affairs in
the Department of Clinical Pharmacy at
the University of California, San Francisco
(UCSF) School of Pharmacy. She also holds a faculty
appointment in the UCSF School of Nursing Department of
Community Health Systems. She received her PharmD from
UCSF in 1985 and MPH from San Jose State University
in 2005. Prior to receiving a faculty appointment in 2001,
Youmans worked as a pharmacist in the hospital and community
pharmacy settings. She currently serves as Clinical
Pharmacist at Glide Health Services, a nurse-managed primary
care clinic for homeless and underinsured citizens of
San Francisco. Her focus is medication management and
adherence strategies. Youmans teaches on the topics of public
health, communication, and cultural competence for the
school and various professional pharmacy organizations.
Her research interests include health literacy, health communication,
health disparities, global health, and pharmacy
education.
Selected as Fellows by APhA–APRS
Jamie C. Barner, PhD,
received her BS in pharmacy from the
University of Texas and PhD in pharmacy
administration from Purdue University.
Barner has worked in community pharmacy,
pharmaceutical industry, and managed
care. She has been a faculty member at the
University of Texas College of Pharmacy for 14 years. She has
held several leadership positions in APhA, including Chair
of the APhA–APRS Economic, Social, and Administrative
Sciences (ESAS) Section; ESAS Contributed Papers; Annual
Meeting Education Committee; and Medication Therapy
Management (MTM) Emerging Issues Committee. She was
also appointed by APhA to serve on the Pharmacy Quality
Alliance Medication Adherence Committee. Barner is a
Fellow of the AACP Academic Leadership Program. Barner
teaches health care systems, pharmacy services, pharmacoeconomics,
research methods, and data analysis. Barner’s
research interests include MTM, health outcomes, and
medication adherence, and she has published more than 55
peer-reviewed papers and presented more than 120 papers at
professional meetings.
Barry L. Carter, PharmD, FCCP,
FAHA, FASH, BCPS,
received his BS in pharmacy from the
University of Iowa (1978) and his PharmD
from the Medical College of Virginia (1980).
He completed a postdoctoral fellowship in
Family Practice at the University of Iowa
(1981). He is currently the Patrick E. Keefe Professor in
Pharmacy at the University of Iowa College of Pharmacy
and a Professor in the university’s Department of Family
Medicine. He has published more than 180 research papers,
reviews, and book chapters. Carter’s research team recently
published the results of a randomized, controlled clinical
trial of physician–pharmacist collaboration to improve
blood pressure control. He has received grants from the
National Heart, Lung, and Blood Institute (NHLBI) and
Department of Veterans Affairs as principal investigator for
funds totaling more than $18 million since 2003. Carter
was a member of the NHLBI National High Blood Pressure
Education Program Committee, and he was a member of
the Fifth, Sixth, and Seventh Joint National Committees on
Prevention, Detection, Evaluation, and Treatment of High
Blood Pressure (JNC-5, 6, and 7). Carter is currently a member
of JNC-8, which should be finalized in 2013.
Richard A. Hansen, PhD, RPh,
is Sandra Kent Gilliland and David Louie
Gilliland Professor and Head of the
Department of Pharmacy Care Systems in
the Harrison School of Pharmacy at Auburn
University. He holds a bachelor’s degree in
pharmacy from the University of Wisconsin
and a PhD in social, administrative, and clinical pharmacy
from the University of Minnesota. Prior to joining Auburn
University, he was Associate Professor of Pharmaceutical
Outcomes and Policy in the Eshelman School of Pharmacy at
the University of North Carolina. Hansen’s research focuses
on helping policymakers, clinicians, and consumers make
more informed decisions about medication use. His work
has been funded by numerous organizations, including the
National Institutes of Health, the Agency for Healthcare
Research and Quality, and the Foundation for the National
Institutes of Health. He has worked extensively in the area
of comparative effectiveness research and drug safety, and he
teaches classes related to this work.
Anandi V. Law, BSPharm, MS,
PhD,
is Professor and Chair, Department of
Pharmacy Practice and Administration at
Western University of Health Sciences. She
received her BPharm from the University of
Mumbai, India, and her MS in pharmaceutics
and PhD in pharmacy administration from the Ohio State
University. Law’s professional and scholarly interests include
the impact of pharmacists on patient medication outcomes,
8 The American Pharmacists Association